首页> 外文期刊>BMC Psychiatry >Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: a protocol of a pragmatic randomized controlled trial (ZELF-i)
【24h】

Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: a protocol of a pragmatic randomized controlled trial (ZELF-i)

机译:基于经验采样方法的自我监控和个性化反馈,作为促进抑郁症治疗的工具:实用随机对照试验(ZELF-i)的协议

获取原文
           

摘要

Depression is a leading cause of disability worldwide. To reduce the societal burden and improve quality of life for individual patients, treatments for depression need to be optimized. There is a particular need for person-tailored interventions that reinforce self-management of patients. Systematic self-monitoring and personalized feedback through the Experience Sampling Method (ESM) could provide such a person-tailored, empowering intervention that enhances treatment outcomes. The primary aim of this study is to investigate the efficacy of self-monitoring and personalized feedback as an add-on tool in the treatment of depressive complaints in a natural setting. The ZELF-i study is a pragmatic multi-site randomized controlled trial (RCT). We aim to recruit 150 individuals with depressive symptoms aged between 18 and 65?years, who have an intake for outpatient basic or specialized treatment at a mental health care organization in the North of the Netherlands. After the intake, participants will be randomly allocated to one of three study arms: two experimental groups engaging in 28?days of systematic self-monitoring (5 times per day) and receiving weekly personalized feedback on positive affect and activities (“Do”-module) or on negative affect and thinking patterns (“Think”-module), and a control group receiving no additional intervention. Self-report inventories of depressive symptoms, psychosocial functioning and feelings of empowerment will be administered before and after the intervention period, and at follow-up measurements at 1, 2, 3 and 6?months. The patient-experienced utility of the intervention will be investigated by a combination of quantitative and qualitative research methods. The present study is the first to examine the effects of add-on self-monitoring and personalized feedback on depressive complaints in clinical practice. It is also the first to evaluate two different ESM modules targeted at both of depression’s core symptoms. Lastly, it is the first study that uses a combination of qualitative and quantitative methods to evaluate the patient-experienced utility of ESM with personalized feedback as an intervention for depression. Results of the present study may improve treatment for depression, if the intervention is found to be effective. Dutch Trial Register, NTR5707 , registered prospectively 1 February 2016.
机译:抑郁症是全球致残的主要原因。为了减轻社会负担并改善个别患者的生活质量,需要优化抑郁症的治疗方法。特别需要针对个人量身定制的干预措施,以加强患者的自我管理能力。通过经验抽样方法(ESM)进行的系统性自我监控和个性化反馈可以提供这种针对个人的,可增强治疗效果的干预措施。这项研究的主要目的是研究在自然环境中自我监控和个性化反馈作为治疗抑郁症的附加工具的功效。 ZELF-i研究是一项实用的多站点随机对照试验(RCT)。我们的目标是招募150名年龄在18至65岁之间的抑郁症状患者,这些患者在荷兰北部的精神保健组织接受门诊基本或专门治疗。摄入后,参与者将被随机分配到三个研究小组之一:两个实验小组,进行28天的系统自我监控(每天5次),并每周收到有关积极影响和活动的个性化反馈(“做”-模块)或负面影响和思维方式(“思考”模块),而对照组则没有其他干预。在干预期前后,以及在1、2、3和6个月时进行随访时,将对抑郁症状,心理社会功能和增强能力的自我报告进行管理。将通过定量和定性研究方法的组合来研究患者体验的干预措施。本研究是第一个检查附加自我监控和个性化反馈对临床实践中抑郁症患者的影响的研究。这也是第一个评估针对抑郁症两种核心症状的两种不同ESM模块的方法。最后,这是第一项使用定性和定量方法相结合的方法来评估患者体验的ESM效用以及个性化反馈作为抑郁症干预措施的研究。如果发现有效,本研究的结果可能会改善抑郁症的治疗。荷兰审判注册簿NTR5707,预期于2016年2月1日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号